Feature
Article
Data Analysis and the IRB: A
Guide for BUMC Investigators
By Don Allensworth-Davies, MSc
Statistical Manager, Data Coordinating Center, BUSPH
IRB Reviewer, Panel Blue
Issue: March, 2006
Author has nothing to disclose with regards
to commercial support.
Educational Objectives:
- Explain how data analysis relates to human subjects' protection
- Describe the six components that the IRB reviews in a data analysis
plan
- Describe the two different ways of justifying sample size on the IRB
application
- Identify some common study designs that require special analytic methods
PRINT
|
CLOSE WINDOW
Introduction
“To write it, it took three months; to conceive it
three minutes; to collect the data in it — all my life.” F.
Scott Fitzgerald, referring to his novel This Side of Paradise
in a letter to the Booksellers’ Convention, April 1920.
All
research studies begin with an idea. The idea might be possible risk factors
for disease scrawled on the back of an envelope or a series of research
hypotheses that evolve over several years. Once conceived, a study protocol
is then written either as part of a grant application, an IRB application,
or both. Finally, IRB approval is obtained and data collection begins.
While, hopefully, your study will not require a lifetime of data collection,
having a well-designed study and analysis plan is an important part of
the research procedures. The purpose of this article is to describe what
the IRB considers in reviewing a data analysis plan (i.e., Section G of
the BUMC IRB application) and tips for preparing the analysis plan for
your study.
Data Analysis and Human Subjects'
Protection
Federal
regulations define research as a “systematic investigation, including
research development, testing and evaluation, designed to develop or contribute
to generalizable knowledge” (45
CFR 46.102(d)). Analysis is the means by which individual data points
are summarized to contribute to scientific knowledge and to benefit society.
Federal criteria for IRB approval of research mandate that “risks
to subjects are minimized by using procedures which are consistent with
sound research design and which do not unnecessarily expose subjects to
risk” (45
CFR 46.111). Often investigators do not realize that the research
procedures include the data analysis. Conducting an analysis that is inappropriate
for the study design or for the type of data collected can bias the results
of the research. While a small amount of bias may not affect the final
study findings, a large
amount can lead to incorrect conclusions. There are ethical implications
of using an inappropriate study design or analysis. Both can result in
bias that may lead to incorrect scientific conclusions of little benefit
to either science or society, thereby exposing subjects to unnecessary
risk. For more information on this topic see Weinberg and Kleinman, “Good
Study Design and Analysis Plans as Features of Ethical Research with Humans”,
IRB: Ethics and Human Research, September/October 2003.
What the IRB Considers in Reviewing an Analysis
Plan
There
are two questions that the IRB asks for each analysis plan: 1) Is
the sample size adequate to answer the research question? And 2)
Is the analysis plan clearly described and adequate to answer the
research question? Inherent in these questions are six components:
1) A sample size that is large enough to provide sufficient data without
placing more subjects at risk than is necessary
2) An appropriate justification for the sample size
3) A description of the specific variables that will be analyzed
4) A description of the comparisons that will be made
5) Statistical methods that are appropriate for the study design and the
type of information collected
6) How the investigator will know whether the research objectives have
been met
1) A sample size that is large
enough to provide sufficient data without placing more subjects at risk
than is necessary
Sample
sizes for each study will be different depending on the study design and
objectives. For example, to detect a small difference between one group
of adults that receives a research counseling intervention and a second
group that receives standard of care counseling, a hundred or more subjects
may need to be enrolled. Conversely, in a laboratory study where cells
are being observed, blood samples may only need to be obtained from a
very small number of subjects.
The IRB also thinks about sample size differently than investigators.
In addition to knowing how many subjects will be recruited locally at
BUMC and how many worldwide, the IRB wants three types of subjects to
be included in the sample size totals:
- Subjects who consented and participated until the end of the study
- Subjects who consented but withdrew, dropped out, or were terminated
before the end of the study
- Subjects who were screened but not enrolled IF
they were placed “at risk” during the screening process
(e.g., blood was drawn or identifiable information was collected)
The same subject types that are included in your sample size totals should
also be included in the annual Progress Report/ Final Report enrollment
tables (Sections PR1 and PR2).
Sample Size Tips:
- The total sample size reported in the Progress Report must not
be greater than the total approved by the IRB
- If you need to change your sample size, you must submit an amendment
to the IRB in INSPIR describing the reason for the change
- The local sample size must always be equal to
(if BUMC is the only study site) or less than
(if BUMC is one of many study sites) the worldwide sample size
- If you are conducting research and having contact with human subjects
in another country, then these subjects "belong to BUMC" and
must be reported in both the local and worldwide sample sizes
- If data are being collected about both the subject and about another
person through the subject, then both must be counted in the sample
size (e.g., mother-child, partners’ or twins’ studies)
- If a study involves interviewing or surveying multiple groups (e.g.,
patients, physicians, and nurses) ALL SUBJECTS
must be included in the sample size
2) An appropriate justification for the
sample size
There are two ways that a sample size is considered by the IRB to be
appropriately justified. The first, and preferred, method is a statistical
justification. This may be through a power calculation or confidence interval
approach appropriate to the study design to determine how many subjects
will be needed to answer the research question(s). In describing the calculation
in the IRB application, any assumptions that were made and the statistical
parameters are included.
In some studies, the sample size may be based on feasibility.
This justification may be based on:
the investigator’s knowledge of the number of subjects that can
be realistically recruited;
Example:
The investigator would like to study syphilis and recruit research subjects
from an STD clinic that treats an average of 15 syphilis cases per year.
The study is expected to enroll subjects for five years; the maximum feasible
sample size is 75.
OR the resources available to the investigator
to conduct the research.
Example #1: A funding agency requests an exploratory study before deciding
whether to fund a larger study. The investigator receives enough funding
to enroll 25 subjects.
Example
#2: An investigator is conducting a sleep study and has three rooms
equipped with sleep monitors available for two nights per week. A maximum
of six subjects can be enrolled per week.
**IMPORTANT: Simply stating that the research
is a pilot study is NOT adequate justification of sample size
3) A description of the specific variables
that will be analyzed
Examples:
sex, age, education, income.
4) A description of the comparisons that
will be made
Examples:
Comparing proportions between two groups, pre-/post- measurements, rates
in exposed to rates in unexposed.
5) Statistical methods that are appropriate
for the study design and the type of information collected
Investigators are strongly encouraged to consult with someone who has
expertise in study design and statistical analysis to identify the methods
that are most appropriate for the study. Factors such as whether the variables
to be analyzed are nominal, ordinal or continuous, normally or non-normally
distributed, and how much data are missing, will also determine which
methods are best for your analysis.
Some study designs require special methods for analysis. Examples include:
- Longitudinal/case-crossover studies: methods for repeated measurements/pairs.
Matched
case-control studies (e.g., matching controls to cases based on age
or gender): methods that take the matching into account.
- Focus groups and unstructured subject interviews: qualitative methods.
6) How the investigator will know whether
the research objectives have been met
The
IRB has reviewed very detailed analysis plans, with detailed description
of the variables to be analyzed, elegant statistical methods, regression
equations, and even graphs. Yet sometimes investigators so lose themselves
in the methods that they forget to tell the IRB how each part of the analysis
plan relates to the study objectives. How will the investigator know if
the research question has been answered? Will this be determined by a
difference between baseline and follow-up measures, a statistic, or a
specific outcome such as subjects remaining free of disease? Organizing
the analysis plan by the study objectives is one way to clearly communicate
this and facilitate IRB review.
Example: Study Objective #1, Identify Demographic Differences in Unsafe
Sexual Behavior: To test for differences in proportions between different
groups classified by sex, age, education, and income, we will use chi-square
or Fisher's exact tests (if data are sparse). Conventional criteria (p
< 0.05) will be used to identify statistically significant differences.
Characteristics of a Good Analysis Plan
A
good analysis plan includes information on what comparisons will be made
to evaluate each study objective, the methods that will be used, and how
the researcher will know if the objectives of the research are met. Ultimately,
a well-designed analysis will reward the investigator by increasing the
accuracy and validity of the research results while reducing bias.
To learn more about this topic, click
here.
The author wishes to thank Christine E. Chaisson, MPH and Janice M. Weinberg,
ScD for their editorial assistance with this article.
Top
Quiz
This Quiz applies to the recertification period from July 1, 2007 to June
30, 2009. CME credits are also available.
Click
here and close window if you are a BUMC researcher
and would like to take the quiz now.
Close
Window
|